LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 16.29 | 84.90 | 1044 | 766 | 1.3614 | 1.2041 | MN20160318_Q02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 17.99 | 84.90 | 47 | 898 | 0.0523 | -0.1594 | MN20160318_Q02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 17.99 | 84.90 | 1130 | 898 | 1.2570 | 1.1390 | MN20160318_Q02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 17.99 | 84.90 | 31 | 898 | 0.0345 | -0.2562 | MN20160318_Q02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 17.99 | 84.90 | 1040 | 898 | 1.1569 | 1.0875 | MN20160318_Q02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 19.69 | 84.90 | 139 | 1239 | 0.1122 | 0.1360 | MN20160318_Q02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 19.69 | 84.90 | 1077 | 1239 | 0.8690 | 0.9287 | MN20160318_Q02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 19.69 | 84.90 | 43 | 1239 | 0.0347 | -0.1613 | MN20160318_Q02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 19.69 | 84.90 | 1079 | 1239 | 0.8706 | 0.9296 | MN20160318_Q02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 21.40 | 84.90 | 200 | 1454 | 0.1375 | 0.2325 | MN20160318_Q02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 21.40 | 84.90 | 1192 | 1454 | 0.8194 | 0.9052 | MN20160318_Q02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 21.40 | 84.90 | 43 | 1454 | 0.0296 | -0.1529 | MN20160318_Q02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 21.40 | 84.90 | 1093 | 1454 | 0.7514 | 0.8653 | MN20160318_Q02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 23.10 | 84.90 | 231 | 1616 | 0.1429 | 0.2655 | MN20160318_Q02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 23.10 | 84.90 | 1206 | 1616 | 0.7462 | 0.8669 | MN20160318_Q02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 23.10 | 84.90 | 51 | 1616 | 0.0316 | -0.1130 | MN20160318_Q02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 23.10 | 84.90 | 1027 | 1616 | 0.6354 | 0.7976 | MN20160318_Q02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 24.81 | 84.90 | 332 | 1769 | 0.1876 | 0.3651 | MN20160318_Q02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 24.81 | 84.90 | 1144 | 1769 | 0.6465 | 0.8105 | MN20160318_Q02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 24.81 | 84.90 | 64 | 1769 | 0.0362 | -0.0625 | MN20160318_Q02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 24.81 | 84.90 | 1013 | 1769 | 0.5725 | 0.7609 | MN20160318_Q02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 26.51 | 84.90 | 361 | 1923 | 0.1877 | 0.3793 | MN20160318_Q02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 26.51 | 84.90 | 1192 | 1923 | 0.6198 | 0.7984 | MN20160318_Q02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 26.51 | 84.90 | 53 | 1923 | 0.0276 | -0.0994 | MN20160318_Q02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 26.51 | 84.90 | 1013 | 1923 | 0.5267 | 0.7345 | MN20160318_Q02 | N22 |